Intrexon | XON - Przychody Ze Sprzedaży





Obroty Zmiana Data
Agenus USD 33.7M 500K 2026-03
Alaunos Therapeutics USD 2K 2K 2025-03
Amgen USD 8.62B 1.28B 2026-03
Anika Therapeutics USD 30.62M 2.8M 2025-12
Arrowhead Research USD 73.74M 190.29M 2026-03
AstraZeneca USD 15.29B 213M 2026-03
Bristol-Myers Squibb USD 11.49B 1.01B 2026-03
Gilead Sciences USD 7B 930M 2026-03
GlaxoSmithKline GBP 7.63B 991M 2026-03
Heron Therapeutics USD 40.59M 2.38M 2025-12
Incyte USD 1.27B 240M 2026-03
Intrexon USD 717K 511K 2024-06
Karyopharm Therapeutics USD 34.08M 3.54M 2025-12
Ligand Pharmaceuticals USD 51.72M 7.94M 2026-03
MacroGenics USD 20.8M 20.43M 2026-03
MannKind USD 90.2M 21.76M 2026-03
Merck USD 16.29B 110M 2026-03
Novartis USD 13.11B 226M 2026-03
Rigel Pharmaceuticals USD 55.31M 18.47M 2024-09
Roche Holding CHF 15.65B 274.5M 2025-12
Sangamo BioSciences USD 356K 125K 2024-06
Thermo Fisher Scientific USD 11.01B 1.2B 2026-03
Veracyte USD 139.07M 1.53M 2026-03
Xencor USD 4.51M 23.73M 2026-03